Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557790 · ClinicalTrials.gov registry record · NA
Proton Radiotherapy for Stage I, IIA, and IIB Seminoma
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01557790 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 5 participants.
The verdict
NCT01557790, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility portion of the study patients will be evaluated to determine acute toxicity. If the study is deemed feasible the principal investigator (PI) hopes that proton RT will reduce the lethargy rate as compared to photon radiation therapy (RT).
Interventions
- RADIATION Proton Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557790
The ClinicalTrials.gov registry entry for NCT01557790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Radiation Therapy is the first listed.
NCT01557790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557790 about?
NCT01557790 is a clinical study titled "Proton Radiotherapy for Stage I, IIA, and IIB Seminoma". Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility port...
What is the current status of trial NCT01557790?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-03. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01557790?
The interventions under investigation include: Proton Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01557790?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.